EAGLE PHARMACEUTICALS, INC.【EGRX】Cash flow
Market cap
$14.29K
P/E ratio
| 2014/09 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | |
| Stock-based compensation | 1 | 4 | 10 | 15 | 19 | 22 | 25 | 20 | 16 |
| Cash from operations | -14 | -10 | 53 | 59 | 52 | 56 | 49 | 28 | 51 |
| Capital expenditures | -0 | -2 | -2 | -4 | -0 | -1 | -1 | -0 | -0 |
| Cash from investing | -20 | -2 | -46 | -5 | -0 | -1 | -18 | -5 | -87 |
| Repurchases of common stock | - | - | 37 | 44 | 73 | 18 | 35 | 21 | 18 |
| Proceeds from issuance of term debt, net | - | - | - | - | - | - | - | - | 50 |
| Repayments of term debt | - | - | - | 1 | 4 | 6 | 5 | 8 | 52 |
| Cash from financing | 46 | 56 | -34 | 8 | -88 | -24 | -38 | -28 | -6 |
| Free cash flow | |||||||||
| FCF margin (%) |